tradingkey.logo
tradingkey.logo

STAAR Surgical Co

STAA
23.350USD
-0.280-1.18%
終値 12/26, 16:00ET15分遅れの株価
1.15B時価総額
損失額直近12ヶ月PER

STAAR Surgical Co

23.350
-0.280-1.18%

詳細情報 STAAR Surgical Co 企業名

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

STAAR Surgical Coの企業情報

企業コードSTAA
会社名STAAR Surgical Co
上場日Feb 24, 1992
最高経営責任者「CEO」Farrell (Stephen C)
従業員数1157
証券種類Ordinary Share
決算期末Feb 24
本社所在地1911 Walker Ave
都市MONROVIA
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号91016
電話番号16263037902
ウェブサイトhttps://www.staar.com/
企業コードSTAA
上場日Feb 24, 1992
最高経営責任者「CEO」Farrell (Stephen C)

STAAR Surgical Coの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
46.54K
+82.00%
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
46.54K
+82.00%
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
Others
18.18M
41.02%
Japan
10.91M
24.63%
U. S.
5.63M
12.71%
China
5.30M
11.96%
South Korea
4.29M
9.69%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
Broadwood Capital, Inc.
30.19%
BlackRock Institutional Trust Company, N.A.
13.23%
The Vanguard Group, Inc.
8.56%
Yunqi Capital Limited
5.03%
State Street Investment Management (US)
3.84%
他の
39.14%
株主統計
株主統計
比率
Broadwood Capital, Inc.
30.19%
BlackRock Institutional Trust Company, N.A.
13.23%
The Vanguard Group, Inc.
8.56%
Yunqi Capital Limited
5.03%
State Street Investment Management (US)
3.84%
他の
39.14%
種類
株主統計
比率
Hedge Fund
48.81%
Investment Advisor
34.47%
Investment Advisor/Hedge Fund
18.71%
Research Firm
2.92%
Pension Fund
1.13%
Bank and Trust
0.58%
Individual Investor
0.49%
Insurance Company
0.04%
Sovereign Wealth Fund
0.03%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
2023Q2
667
52.64M
108.92%
-2.50M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Broadwood Capital, Inc.
13.52M
27.39%
--
--
Sep 24, 2025
BlackRock Institutional Trust Company, N.A.
6.72M
13.61%
-298.81K
-4.26%
Jun 30, 2025
The Vanguard Group, Inc.
4.38M
8.88%
-1.02M
-18.96%
Jun 30, 2025
Yunqi Capital Limited
2.50M
5.07%
+88.77K
+3.68%
Sep 19, 2025
State Street Investment Management (US)
2.00M
4.06%
+7.97K
+0.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.19M
2.42%
+3.33K
+0.28%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.53%
State Street SPDR S&P Health Care Equipment ETF
1.67%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.79%
Royce Quant Small-Cap Quality Value ETF
0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
詳細を見る
AltShares Merger Arbitrage ETF
比率2.71%
ProShares Merger ETF
比率2.53%
State Street SPDR S&P Health Care Equipment ETF
比率1.67%
NYLI Merger Arbitrage ETF
比率0.87%
Invesco S&P SmallCap Health Care ETF
比率0.79%
Royce Quant Small-Cap Quality Value ETF
比率0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
比率0.13%
iShares S&P Small-Cap 600 Growth ETF
比率0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
比率0.1%
iShares ESG Select Screened S&P Small-Cap ETF
比率0.1%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

STAAR Surgical Coの上位5名の株主は誰ですか?

STAAR Surgical Coの上位5名の株主は以下のとおりです。
Broadwood Capital, Inc.は13.52M株を保有しており、これは全体の27.39%に相当します。
BlackRock Institutional Trust Company, N.A.は6.72M株を保有しており、これは全体の13.61%に相当します。
The Vanguard Group, Inc.は4.38M株を保有しており、これは全体の8.88%に相当します。
Yunqi Capital Limitedは2.50M株を保有しており、これは全体の5.07%に相当します。
State Street Investment Management (US)は2.00M株を保有しており、これは全体の4.06%に相当します。

STAAR Surgical Coの株主タイプ上位3種は何ですか?

STAAR Surgical Coの株主タイプ上位3種は、
Broadwood Capital, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

STAAR Surgical Co(STAA)の株式を保有している機関の数はいくつですか?

2025Q3時点で、STAAR Surgical Coの株式を保有している機関は511社あり、保有株式の総市場価値は約49.83Mで、全体の100.45%を占めています。2025Q2と比較して、機関の持ち株は-9.13%増加しています。

STAAR Surgical Coの最大の収益源は何ですか?

FY2025Q2において、--部門がSTAAR Surgical Coにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI